Comparison of T2 and T2*-weighted MR molecular imaging of a mouse model of glioma

[1] Blasiak B(2010)Detection of T Magn Res Imag 28 784-789

[2] Tomanek B(2005) changes in an early mouse brain tumor J Neuropathol Exp Neurol 64 479-489

[3] Abulrob A(2003)Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas Circulation 108 336-341

[4] Iqbal U(2005)Imaging tumor angiogenesis with contrast ultrasound and microbubbles targeted to α Clin Cancer Res 11 8600-8605

[5] Stanimirovic D(2010)ß Adv Drug Deliv Rev 62 284-304

[6] Albaghdadi H(2010)Magnetic resonance imaging characteristics predicts epidermal growth factor receptor amplification status in glioblastomas Pharmacol Res 26 126-143

[7] Foniok T(2012)Design and fabrication of magnetic nanoparticles for targeted drug delivery and therapy Neuro Oncol 14 53-63

[8] Lun X(2012)From iron oxide nanoparticle towards advanced iron-based inorganic materials designed for biomedical applications J Phys Chem Lett 3 524-529

[9] Forsyth P(2012)Evaluation of brain tumor vessels specific contrast agents for glioblastoma imaging Chem Mater 24 1297-1305

[10] Sutherland RG(2007)NaDyF4 nanoparticle as T2 contrast agent for ultra-high field magnetic resonance imaging J Magn Reson Imag 26 1634-1641

[1] Blasiak B(2010)Detection of T Magn Res Imag 28 784-789

[2] Tomanek B(2005) changes in an early mouse brain tumor J Neuropathol Exp Neurol 64 479-489

[3] Abulrob A(2003)Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas Circulation 108 336-341

[4] Iqbal U(2005)Imaging tumor angiogenesis with contrast ultrasound and microbubbles targeted to α Clin Cancer Res 11 8600-8605

[5] Stanimirovic D(2010)ß Adv Drug Deliv Rev 62 284-304

[6] Albaghdadi H(2010)Magnetic resonance imaging characteristics predicts epidermal growth factor receptor amplification status in glioblastomas Pharmacol Res 26 126-143

[7] Foniok T(2012)Design and fabrication of magnetic nanoparticles for targeted drug delivery and therapy Neuro Oncol 14 53-63

[8] Lun X(2012)From iron oxide nanoparticle towards advanced iron-based inorganic materials designed for biomedical applications J Phys Chem Lett 3 524-529

[9] Forsyth P(2012)Evaluation of brain tumor vessels specific contrast agents for glioblastoma imaging Chem Mater 24 1297-1305

[10] Sutherland RG(2007)NaDyF4 nanoparticle as T2 contrast agent for ultra-high field magnetic resonance imaging J Magn Reson Imag 26 1634-1641